[5-chloro-2-(triazol-1-yl)phenyl]-[(3S)-3-[(5-fluoro-2-pyridinyl)oxymethyl]-2-propylpiperidin-1-yl]methanone
C23H25ClFN5O2 — CID 130329748
Data last refreshed: (MolForge compound catalog, from PubChem)
About [5-chloro-2-(triazol-1-yl)phenyl]-[(3S)-3-[(5-fluoro-2-pyridinyl)oxymethyl]-2-propylpiperidin-1-yl]methanone
[5-chloro-2-(triazol-1-yl)phenyl]-[(3S)-3-[(5-fluoro-2-pyridinyl)oxymethyl]-2-propylpiperidin-1-yl]methanone (PubChem CID 130329748) has the molecular formula C23H25ClFN5O2 and a molecular weight of 457.94 g/mol. Its IUPAC name is [5-chloro-2-(triazol-1-yl)phenyl]-[(3S)-3-[(5-fluoro-2-pyridinyl)oxymethyl]-2-propylpiperidin-1-yl]methanone.
Molecular Properties
| Compound Name | [5-chloro-2-(triazol-1-yl)phenyl]-[(3S)-3-[(5-fluoro-2-pyridinyl)oxymethyl]-2-propylpiperidin-1-yl]methanone |
|---|---|
| PubChem CID | 130329748 |
| Molecular Formula | C23H25ClFN5O2 |
| Molecular Weight | 457.94 g/mol |
| Exact Mass | 457.17 |
| IUPAC Name | [5-chloro-2-(triazol-1-yl)phenyl]-[(3S)-3-[(5-fluoro-2-pyridinyl)oxymethyl]-2-propylpiperidin-1-yl]methanone |
| SMILES | CCCC1[C@@H](COc2ccc(F)cn2)CCCN1C(=O)c1cc(Cl)ccc1-n1ccnn1 |
| InChI | InChI=1S/C23H25ClFN5O2/c1-2-4-20-16(15-32-22-9-7-18(25)14-26-22)5-3-11-29(20)23(31)19-13-17(24)6-8-21(19)30-12-10-27-28-30/h6-10,12-14,16,20H,2-5,11,15H2,1H3/t16-,20?/m1/s1 |
| InChIKey | BTNZQMMWCFRRFR-QRIPLOBPSA-N |
| XLogP | 4.55 |
| TPSA | 73.14 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 457.94 |
| LogP ≤ 5 | 4.55 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130329748 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.